The Department of Defense this week announced a notable contract award related to the field of chemical, biological, radiological and nuclear (CBRN) defense or life science research of interest for potential applications in biodefense:
Institute for Systems Biology, Seattle, Wash., is being awarded a $7,665,557 cost-type contract for research into pre-symptomatic detection of post-operative sepsis for the Defense Threat Reduction Agency in support of the J9 Research and Development Directorate.
Work will be performed in Seattle, Wash, and is expected to be completed May 29, 2016. Bids were solicited via a broad agency announcement. Defense Threat Reduction Agency, Ft. Belvoir, Va., is the contracting activity (HDTRA1-13-C-0055).